AKY15-HK-301_NEPA Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 27, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Breast Cancer
Interventions
DRUG

NEPA

"Day 1 of each chemotherapy cycle:~1 tablet of NEPA (NETU 300 mg/ PALO 0.50 mg) 1 hour prior to the start of chemotherapy with dexamethasone 12 mg administered orally 30 minutes prior to chemotherapy Days 2 to 3 Dexamethasone. The time and date of intake will be recorded."

Trial Locations (1)

Unknown

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
collaborator

Princess Margaret Hospital, Hong Kong

OTHER_GOV

lead

Chinese University of Hong Kong

OTHER

NCT03386617 - AKY15-HK-301_NEPA Study | Biotech Hunter | Biotech Hunter